The following shareholder list was on Intellego’s Discord. Apparently from May. Some trimming among the top 20.
1 Like
Could the consolidation be over?
4 Likes
Shares acquired through warrants in moderate amounts.
1 Like
These resulted in a dilution of just over 5%, with a price tag of 14.40 crowns per warrant. I probably would have subscribed myself 
2 Likes
Likewise. Well, it’s positive that they got the funds for the second installment of the Daro purchase price, which is due at the end of August.
3 Likes
At Intellego’s annual general meeting, the most important decision seems to have been the change of auditor.
The meeting resolved, in accordance with the proposal presented at the meeting by shareholder Claes Lindahl, to elect the registered auditing firm Deloitte AB with Petter Engdahl as the principal auditor.
5 Likes
Picked up from Discord, someone had been at the general meeting and talked with the CEO. The CEO answered cautiously, of course, as he cannot provide any extra information. However, he had said that Intellego would have already wanted to sign the “Henkel” agreement, but the counterparty is sticking to its own processes. It looks good; the deal is definitely coming during this year.
He had also asked how the products are entering the market. To that, also a cautious response that volumes from existing customers are growing all the time, and large orders are delivered and invoiced in small batches. This was actually already visible in the Q1 report.
“Tried to pump him for more info about onboarding, but he was tight-lipped and said that if it had been up to him, the global agreement would have been up and running a long time ago; implicitly, he said that the counterparty is slow with lots of processes etc., but the plan is for it to be finalized during 2024.”
“Also asked about the growth rate of end consumption now that repeat orders are at 70%. He was very cautious there as well, but said that no one benefits from inventory buildup; instead, they portion out large orders into partial deliveries based on the end consumption rate, so that inventory doesn’t increase and they receive partial payments continuously. He didn’t want to give a percentage figure and said it’s hard to estimate, but implicitly I interpreted it as at least 70%. He also said that order sizes from recurring customers are becoming increasingly larger.”
1 Like
Here is also a link to Intellego’s US site. You can find a good list of partners there.
3 Likes
A deal is coming. Unfortunately, the text is in the other national language.
INTELLEGO
DISTRIBUTION AGREEMENT IN CHINA WORTH AT LEAST 16.2 MILLION USD (Direkt)
2024-06-26 15:05
STOCKHOLM (Nyhetsbyrån Direkt) Intellego, which provides color indicators showing the effect of irradiation with, among other things, ultraviolet light, has entered into an exclusive distribution agreement in China with Zhongyou Medical.
This is stated in a press release.
Intellego’s counterparty has agreed to purchase products from Intellego for at least 16.2 million dollars over a three-year period.
Stock Editorial Desk +46 8 51917911 https://twitter.com/Borsredaktion
Nyhetsbyrån Direkt
The deal’s impact over the next 3 years is 5.4 million USD annually. This is a significant agreement; the company’s market value is 65 million USD according to the market.
6 Likes
Intellego Technologies announces that Zhongyou Medical (Likang) will receive an exclusive market right to sell and market a certain type of Intellego`s UVC dosimeters and UVC devices in the healthcare sector in China. In exchange for the exclusive market right, Zhongyou Medical have committed to purchase products from Intellego to a minimum value of 16.2 million USD over a three-year period. Deliveries and payments will start immediately.
“We look forward to this collaboration and to expand our reach in the Asian healthcare market. We are impressed by Shanghai Zhongyou Medical High-Tech Co., Ltd market reach and we look forward to launch Intellego’s products in China for a start, with the potential for expansion from there”, says Claes Lindahl, CEO of Intellego Technologies.
“We look forward to capitalizing on this unique and huge market given the increasing demand to validate UVC disinfection results in the China healthcare market and we are impressed by Intellego`s technology and well- established global recognition.” Says Zhuang Zhong, President of Zhongyou Medical.
Zhongyou Medical (Likang) is a wholly owned subsidiary of Jiangsu Yuyue Medical Equipment and Supply Co., Ltd, which is listed on the Shenzhen Stock market, a leading distributor of a variety of disinfectant products into more than 3000 hospitals in China nationally.
Yuwell medical, with full name of Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. has established 12 R&D centers and 9 production bases in Shanghai, Shenzhen, Nanjing, Suzhou, Danyang, Tibet, the Netherlands, Germany, Italy, and other places, forming a complete global R&D, production, marketing, and service network that serves more than 300,000 medical institutions worldwide and covers 131 countries and regions, benefitting 300 million
Tässä vielä tiedote Inden omilta sivuilta. En muistanut tämän olevan seurannassa.
5 Likes
This announcement probably approaches the record for the longest stock exchange release ever 
In line with previous communication, Intellego Technologies has recived payments from external customers of over 50 million SEK during Q2.
The full Q2 report will be published on 26th of August.
The mentioned numbers are preliminary.
Q1 operating cash flow was around the 34m SEK level, so if part of that over 50m amount doesn’t evaporate somewhere, it’s quite a nice direction for the cash flow.
7 Likes
Intellego’s CEO has purchased 36,000 shares of the company for approximately 1 million krona. Currently owns 3.3 million shares. A fairly good sign. The share price has been rising gradually while waiting for the Henkel agreement.
4 Likes
Ecolight Biosafety is listed as a partner of Intellego on their website. In a LinkedIn post, they announced cloud-based usage/scanning for UV dosimeters. More information regarding the significance of this solution for Intellego will certainly be available in the future.
5 Likes
It could be quite significant, at least in locations where it is beneficial to preserve the dosimeter’s “result,” such as a hospital environment.
If we speculate a bit, would it be possible in the future to automatically switch off the UV light (saving energy and lamps) via a camera when the dosimeter reaches the correct color? In other words, could UV treatment be automated that way?
1 Like
I’m wondering if a dosimeter is necessary at all if UV measurement becomes digitalized in the future. If you put a filter in front of the camera lens that only lets through the desired UV light and use a long exposure time, the camera itself could serve as a meter for UV accumulation.
In terms of valuation, the company is indeed very interesting.
1 Like
Any simple and fast method that is sufficiently accurate (quantitative) can capture the market. Before Intellego, the situation was that there were no methods simple, fast, and accurate enough to measure the amount of UV light, especially at specific wavelengths.
But yes, one has to stay alert and follow developments.
2 Likes
Interesting article about automatic disinfection robots (UV) and a good overview of disinfection methods. Chrome translated it nicely into Finnish and it’s quite understandable.
https://www.sciencedirect.com/science/article/pii/S0921889022002214
5 Likes
Article/news from Intellego’s website regarding the use of UV light in eliminating microorganisms and how Intellego’s dosimeters are part of its visual verification.
2 Likes
Video and blog post in which the Latin American Sales Director talks about Intellego’s dosimeters. A good summary of how these work.
2 Likes
Shareholder list for July from Discord. One major seller is Jonas Hagberg, former chairman of the board of Intellego, who stepped down from the position about a year ago. Hagberg still owned 1.4 million shares at the beginning of May.
2 Likes